Related Experiment Video

Updated: Aug 16, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Heavy chain diseases

Dietlind L Wahner-Roedler1, Robert A Kyle

  • 1Division of General Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. wahnerroedler.dietlind@mayo.edu

Best Practice & Research. Clinical Haematology
|July 20, 2005
PubMed

Insights

Heavy chain diseases (HCDs) are rare B-cell cancers producing abnormal immunoglobulin heavy chains. Diagnosis involves detecting deleted heavy chains without light chains, with variable prognoses and limited treatments.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Heavy chain diseases (HCDs) are uncommon B-cell lymphoproliferative disorders.
  • Characterized by truncated monoclonal immunoglobulin heavy chains lacking light chains.
  • Three main classes exist: alpha-HCD (most common), gamma-HCD, and mu-HCD, each with distinct features.

Purpose of the Study:

  • To summarize the characteristics, diagnosis, and treatment of heavy chain diseases.
  • To differentiate HCDs based on immunoglobulin class and associated lymphoma types.
  • To highlight the diagnostic criteria and prognostic variability of HCDs.

Main Methods:

  • Review of literature on heavy chain diseases.
  • Analysis of clinical presentations and histopathologic features.
  • Description of diagnostic methods, including serum and urine analysis.

Main Results:

  • Alpha-HCD presents uniformly as extranodal marginal-zone lymphoma.
  • Gamma- and mu-HCDs show variable presentations as other non-Hodgkin lymphomas or chronic lymphocytic leukemia.
  • Diagnosis requires identifying deleted heavy chains without bound light chains.

Conclusions:

  • HCDs represent a spectrum of B-cell malignancies with distinct subclass characteristics.
  • Early-stage alpha-HCD may respond to antibiotics, while other HCDs lack standardized treatments.
  • Prognosis for HCDs is variable, necessitating further research into effective therapeutic strategies.

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Functional Characterization of Endogenously Expressed Human RYR1 Variants07:59

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Published on: June 9, 2021

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...